13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001515070
Total reported value
$635.1M
$635.1M
43 檔
83.5%
During the Q3 2025 filing period, Tetragon Partners GP Ltd (CIK: 0001515070) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $635.1M across 43 reported positions.
In Q3 2025, Tetragon Partners GP Ltd displayed an active expansion posture, initiating 18 new positions and adding to 11 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PATH | Uipath Inc - Class A | Stock-Tech | 30.33% | -1.34% | +23.52% | |
| 2 | BABA 0.5 06-01-31Bond | Alibaba Group Holding | Bond | 23.39% | — | -5.00% | |
| 3 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | ETF-High Yield | 8.69% | — | -10.19% | |
| 4 | KGEI | Kolibri Global Energy Inc | Stock-Other | 5.24% | -1.95% | +0.02% | |
| 5 | LARCN 1.75 01-15-27Bond | Lithium Argentina AG | Bond | 3.29% | — | +63.22% | |
| 6 | LYFT | Lyft Inc-a | Stock-Tech | 2.94% | -0.28% | — | |
| 7 | CABO 0 03-15-26Bond | Cable One Inc | Bond | 2.78% | — | — | |
| 8 | PRGS 1 04-15-26Bond | Progress Software CORP | Bond | 2.75% | — | — | |
| 9 | OTLY 9.25 09-14-28Bond | Oatly Group AB | Bond | 2.46% | — | — | |
| 10 | CXM | Sprinklr Inc-a | Stock-Other | 2.27% | -0.77% | — | |
| 11 | AUTL | Autolus Therapeutics PLC | Stock-Other | 2.07% | -0.16% | — | |
| 12 | WK | Workiva Inc | Stock-Tech | 1.73% | -0.98% | — | |
| 13 | AGCN 0.375 01-15-27Bond | First Majestic Silver | Bond | 1.07% | — | — | |
| 14 | CLDX | Celldex Therapeutics Inc | Stock-Other | 1.05% | -0.22% | -3.97% | |
| 15 | CELC 2.75 08-01-31Bond | Celcuity Inc | Bond | 1.00% | — | — | |
| 16 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 0.99% | — | -50.00% | |
| 17 | ANNX | Annexon Inc | Stock-Other | 0.86% | -0.27% | -24.82% | |
| 18 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 0.75% | -0.46% | +11.86% | |
| 19 | PHVS | Pharvaris N.V. | Stock-Other | 0.65% | +0.39% | +3.46% | |
| 20 | SRRK | Scholar Rock Holding CORP | Stock-Other | 0.59% | — | +13.92% | |
| 21 | TECX | Tectonic Therapeutic Inc | Stock-Other | 0.51% | +0.02% | +6.51% | |
| 22 | AMLX | Amylyx Pharmaceuticals Inc | Stock-Other | 0.47% | +0.01% | +18.05% | |
| 23 | MBX | Mbx Biosciences Inc | Stock-Other | 0.42% | +0.93% | — | |
| 24 | IMVT | Immunovant Inc | Stock-Other | 0.41% | +0.50% | +27.44% | |
| 25 | DYN | Dyne Therapeutics Inc | Stock-Other | 0.38% | +0.34% | +61.29% | |
| 26 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 0.38% | +0.12% | — | |
| 27 | ALKS | Alkermes plc | Stock-Healthcare | 0.36% | +0.47% | +473.26% | |
| 28 | ABVX | Abivax Sa-adr | Stock-Other | 0.34% | — | — | |
| 29 | SNOW | Snowflake Inc | Stock-Tech | 0.30% | +0.11% | — | |
| 30 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 0.25% | +0.05% | -46.67% | |
| 31 | HBM | Hudbay Minerals Inc | Stock-Other | 0.24% | — | +9.81% | |
| 32 | CCJ | Cameco CORP | Stock-Energy | 0.18% | — | -16.93% | |
| 33 | RLAY | Relay Therapeutics Inc | Stock-Other | 0.16% | +1.33% | -68.08% | |
| 34 | AM6 | Amicus Therapeutics Inc | Stock-Other | 0.13% | — | — | |
| 35 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 0.11% | +0.16% | — | |
| 36 | TECK | Teck Resources Ltd-cls B | Stock-Materials | 0.11% | — | +183.73% | |
| 37 | KROS | Keros Therapeutics Inc | Stock-Other | 0.09% | — | -66.41% | |
| 38 | ✓ | Lithium Argentina AG F | Stock-Other | 0.09% | — | — | |
| 39 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 0.07% | +0.37% | — | |
| 40 | WBI | Waterbridge Infrastruc-cl A | Stock-Other | 0.07% | — | — | |
| 41 | NXE | Nexgen Energy LTD | Stock-Other | 0.05% | — | — | |
| 42 | ✓ | Diana Shipping Inc | Stock-Other | — | — | -22.51% | |
| 43 | SONWQ | Gores Metropoulos Ii -cw28 | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PATH | Uipath Inc - Class A | +9.3% | +23.52% | Add |
| 2 | LYFT | Lyft Inc-a | +0.2% | — | Unchanged |
| 3 | PHVS | Pharvaris N.V. | +0.2% | +3.46% | Add |
| 4 | TECK | Teck Resources Ltd-cls B | +0.1% | +183.73% | Add |
| 5 | HBM | Hudbay Minerals Inc | +0.1% | +9.81% | Add |
| 6 | SONWQ | Gores Metropoulos Ii -cw28 | — | — | Unchanged |
| 7 | ✓ | Diana Shipping Inc | 0% | -22.51% | Trim |
| 8 | CCJ | Cameco CORP | 0% | -16.93% | Trim |
| 9 | CLDX | Celldex Therapeutics Inc | 0% | -3.97% | Add |
| 10 | SNOW | Snowflake Inc | 0% | — | Unchanged |
| 11 | IMVT | Immunovant Inc | -0.1% | +27.44% | Add |
| 12 | AXSM | Axsome Therapeutics Inc | -0.2% | +11.86% | Add |
| 13 | ACAD | Acadia Pharmaceuticals Inc | -0.2% | -46.67% | Trim |
| 14 | RLAY | Relay Therapeutics Inc | -0.2% | -68.08% | Trim |
| 15 | TECX | Tectonic Therapeutic Inc | -0.3% | +6.51% | Add |
| 16 | ANNX | Annexon Inc | -0.3% | -24.82% | Trim |
| 17 | KROS | Keros Therapeutics Inc | -0.3% | -66.41% | Trim |
| 18 | OTLY 9.25 09-14-28Bond | Oatly Group AB | -0.4% | — | Add |
| 19 | AUTL | Autolus Therapeutics PLC | -1% | — | Add |
| 20 | TARS | Tarsus Pharmaceuticals Inc | -1.1% | -50.00% | Trim |
| 21 | LARCN 1.75 01-15-27Bond | Lithium Argentina AG | -1.1% | +63.22% | Add |
| 22 | CXM | Sprinklr Inc-a | -1.9% | — | Unchanged |
| 23 | AGCN 0.375 01-15-27Bond | First Majestic Silver | -2.5% | — | Trim |
| 24 | KGEI | Kolibri Global Energy Inc | -8.2% | +0.02% | Unchanged |
| 25 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | -21.3% | -10.19% | Trim |
| 26 | BABA 0.5 06-01-31Bond | Alibaba Group Holding | — | NEW | New buy |
| 27 | CABO 0 03-15-26Bond | Cable One Inc | — | NEW | New buy |
| 28 | PRGS 1 04-15-26Bond | Progress Software CORP | — | NEW | New buy |
| 29 | INFA1EUR | Informatica Inc - Class A | — | EXIT | Sold out |
| 30 | WK | Workiva Inc | — | NEW | New buy |
| 31 | CELC 2.75 08-01-31Bond | Celcuity Inc | — | NEW | New buy |
| 32 | CYTK 3.5 07-01-27Bond | Cytokinetics Inc | — | EXIT | Sold out |
| 33 | SRRK | Scholar Rock Holding CORP | — | NEW | New buy |
| 34 | SSRMCN 2.5 04-01-39Bond | Ssr Mining Inc | — | EXIT | Sold out |
| 35 | AMLX | Amylyx Pharmaceuticals Inc | — | NEW | New buy |
| 36 | MBX | Mbx Biosciences Inc | — | NEW | New buy |
| 37 | DYN | Dyne Therapeutics Inc | — | NEW | New buy |
| 38 | ARWR | Arrowhead Pharmaceuticals In | — | NEW | New buy |
| 39 | ALKS | Alkermes plc | — | NEW | New buy |
| 40 | ABVX | Abivax Sa-adr | — | NEW | New buy |
| 41 | AM6 | Amicus Therapeutics Inc | — | NEW | New buy |
| 42 | BVN | Cia De Minas Buenaventur-adr | — | EXIT | Sold out |
| 43 | KRYS | Krystal Biotech Inc | — | NEW | New buy |
| 44 | OTLY | Oatly Group AB | — | EXIT | Sold out |
| 45 | ✓ | Lithium Argentina AG F | — | NEW | New buy |
| 46 | RARE | Ultragenyx Pharmaceutical In | — | NEW | New buy |
| 47 | WBI | Waterbridge Infrastruc-cl A | — | NEW | New buy |
| 48 | NXE | Nexgen Energy LTD | — | NEW | New buy |
According to official SEC Form 13F filings, Tetragon Partners GP Ltd reported a total U.S. public equity portfolio value of $635.1M across 43 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including PATH, BABA 0.5 06-01-31, HYG) accounted for 83.5% of total reported equity market value during Q3 2025.
Top New Position Initiated
BABA 0.5 06-01-31
市值: $174.8M
Top Position Liquidated / Trimmed
INFA1EUR
前期市值: $14.0M
During Q3 2025, Tetragon Partners GP Ltd's top holdings by market value included PATH (30.3%)、BABA 0.5 06-01-31 (23.4%)、HYG (8.7%). The largest single position, PATH, represented 30.3% of total portfolio value.
In Q3 2025, Tetragon Partners GP Ltd made 43 total portfolio adjustments, initiating 18 new buys, adding to 11 positions, trimming 9 holdings, and fully liquidating 5 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.